Search by Drug Name or NDC

    NDC 25021-0242-02 Fludarabine Phosphate 25 mg/mL Details

    Fludarabine Phosphate 25 mg/mL

    Fludarabine Phosphate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is FLUDARABINE PHOSPHATE.

    Product Information

    NDC 25021-0242
    Product ID 25021-242_ec7f6839-a01c-4b1b-b4b3-5573037706dd
    Associated GPIs 21300025102020
    GCN Sequence Number 058106
    GCN Sequence Number Description fludarabine phosphate VIAL 50 MG/2 ML INTRAVEN
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 23439
    HICL Sequence Number 006308
    HICL Sequence Number Description FLUDARABINE PHOSPHATE
    Brand/Generic Generic
    Proprietary Name Fludarabine Phosphate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fludarabine Phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name FLUDARABINE PHOSPHATE
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076661
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0242-02 (25021024202)

    NDC Package Code 25021-242-02
    Billing NDC 25021024202
    Package 1 VIAL in 1 CARTON (25021-242-02) / 2 mL in 1 VIAL
    Marketing Start Date 2016-10-15
    NDC Exclude Flag N
    Pricing Information N/A